Serum levels of SPON2 may be used as a auxiliary diagnostic marker to detect early disease and to evaluate the responses to therapy of patients with GC SPON2 promoted the EMT of GC cells by activating the ERK pathway. The gene discussed is GC; the disease is gastric cancer.